News 13 February 2026 - 14 February 2026

ICON (ICLR) stock rebounds after accounting probe shock — what investors watch next

ICON (ICLR) stock rebounds after accounting probe shock — what investors watch next

ICON shares jumped 16% in after-hours trading Friday, recovering some losses after a 40% plunge tied to an internal accounting probe and delayed earnings. The company withdrew 2025 guidance and postponed results to late April as it reviews revenue recognition for 2023–2025. Analysts at Leerink and BofA downgraded the stock and slashed price targets. ICON expects to report material weaknesses in internal controls.
February 14, 2026
Texas Instruments (TXN) stock price rises as inflation cools; insider sales hit SEC filings

Texas Instruments (TXN) stock price rises as inflation cools; insider sales hit SEC filings

Texas Instruments shares rose 1.5% to $226.16 after hours Friday as the chip sector advanced on softer inflation data. SEC filings showed CFO Rafael Lizardi and two senior vice presidents sold shares totaling over $22 million on Feb. 10–11. The company recently announced a $7.5 billion deal to acquire Silicon Labs. U.S. markets will be closed Monday for Presidents Day.
February 14, 2026
CH Robinson stock bounces after AI scare as CEO, CFO buy shares — what CHRW traders watch next

CH Robinson stock bounces after AI scare as CEO, CFO buy shares — what CHRW traders watch next

C.H. Robinson shares climbed 4.9% to $176.01 in after-hours trading Friday, rebounding after a sharp AI-driven selloff hit logistics stocks the day before. CEO David Bozeman and CFO Damon Lee disclosed open-market share purchases. The rout followed Algorhythm Holdings’ launch of an AI freight platform, which triggered fears of disruption across the sector.
February 14, 2026
AbbVie stock price climbs again after Botox lawsuit; what ABBV traders watch next

AbbVie stock price climbs again after Botox lawsuit; what ABBV traders watch next

AbbVie shares rose 1.8% to $231.50 in after-hours trading Friday following updates on its drug pipeline and ongoing litigation over Botox’s inclusion in Medicare price negotiations. Botox made up just over 10% of AbbVie’s $61.16 billion revenue last year. Investors are watching for mid-stage trial results in hidradenitis suppurativa and inflammatory bowel disease later this year. The next court update in the Botox case is expected Monday.
February 14, 2026
Dell stock rebounds 4% after chip-cost jitters; earnings date and next session in focus

Dell stock rebounds 4% after chip-cost jitters; earnings date and next session in focus

Dell shares climbed 4.1% to $117.49 in after-hours trading Friday, rebounding from a 9% drop Thursday triggered by renewed memory-supply concerns. The move followed a volatile session as investors weighed rising component costs and pressure on margins. U.S. markets will close Monday for Presidents Day, with Dell’s next earnings report set for February 26.
February 14, 2026
Astera Labs stock price ticks up after-hours as Amazon warrant and margins dominate ALAB debate

Astera Labs stock price ticks up after-hours as Amazon warrant and margins dominate ALAB debate

Astera Labs shares climbed 2.2% to $129.32 in after-hours trading Friday, following a volatile week that saw the stock drop 31% since Tuesday’s earnings. A new Amazon transaction gives the retailer a warrant to buy up to 3.26 million shares tied to $6.5 billion in product purchases, raising concerns about margin pressure and customer concentration. Astera reported Q4 revenue of $270.6 million and non-GAAP EPS of $0.58.
February 14, 2026
Maplebear (Instacart) stock jumps after upbeat outlook — CART slips in late trading

Maplebear (Instacart) stock jumps after upbeat outlook — CART slips in late trading

Maplebear Inc shares closed up 9.2% at $36.30 Friday after Instacart’s parent forecast first-quarter gross transaction value above Wall Street estimates and reported a 12% rise in fourth-quarter revenue. The company cited strong demand for essentials and ad sales, but flagged higher legal costs including a $60 million FTC settlement. Shares slipped 1.4% after hours as traders weighed rising competition in grocery delivery.
February 14, 2026
IBM stock price rebounds Friday as Confluent vote clears a hurdle heading into U.S. holiday break

IBM stock price rebounds Friday as Confluent vote clears a hurdle heading into U.S. holiday break

IBM shares rose 1.1% to $262.38 Friday, rebounding after a 4.87% drop Thursday. Confluent shareholders approved IBM’s planned acquisition at a Feb. 12 meeting, according to an SEC filing. U.S. stock markets will be closed Monday for Presidents’ Day, with trading set to resume Tuesday. IBM traded between $256.88 and $264.62 on Friday, with about 6.8 million shares changing hands.
February 13, 2026
Vertex Pharmaceuticals stock jumps on 2026 outlook as Casgevy and Journavx come into focus

Vertex Pharmaceuticals stock jumps on 2026 outlook as Casgevy and Journavx come into focus

Vertex Pharmaceuticals shares rose 5.7% to $491.47 after hours Friday following a 2026 revenue forecast of up to $13.1 billion, matching Wall Street’s expectations. Fourth-quarter revenue reached $3.19 billion, with cystic fibrosis drugs Trikafta and Kaftrio accounting for $2.57 billion. Journavx prescriptions topped 550,000 through 2025. Casgevy sales more than tripled from the previous quarter.
February 13, 2026
Freeport-McMoRan stock pops after FCX 10-K: what the 2026 copper outlook means

Freeport-McMoRan stock pops after FCX 10-K: what the 2026 copper outlook means

Freeport-McMoRan shares rose 1.3% to $62.84 Friday, rebounding after a 5.2% drop. The company’s annual filing projected 2026 copper sales of 3.38 billion pounds, gold sales of 800,000 ounces, and $4.3 billion in capital spending. Copper inventories climbed above 1.1 million metric tons, the highest since 2003. Argus Research upgraded FCX to “buy” with a $72 target.
February 13, 2026
KLA (KLAC) stock edges up after-hours as Applied Materials lifts chip tools; India R&D plan in view

KLA (KLAC) stock edges up after-hours as Applied Materials lifts chip tools; India R&D plan in view

KLA shares rose 0.9% to $1,464.13 in after-hours trading Friday, tracking gains in chip-equipment stocks after Applied Materials issued a strong outlook. KLA announced plans to invest up to $400 million over 10 years in a new R&D campus in Chennai, India. U.S. markets reopen Tuesday after Presidents Day, with KLA’s dividend date also approaching.
February 13, 2026
Rocket Lab stock rebounds Friday as hypersonic launch nears — what moved RKLB now

Rocket Lab stock rebounds Friday as hypersonic launch nears — what moved RKLB now

Rocket Lab shares closed up 2.2% at $67.44 Friday before dipping slightly after hours. The company announced its next HASTE rocket launch, carrying Hypersonix’s DART AE, will open a window in late February from Virginia. Investors await Rocket Lab’s quarterly results on Feb. 26 and updates on its Neutron rocket after a recent test failure. Broader tech and space stocks saw volatility tied to macro data and sector financing news.
February 13, 2026
Newfoundland power outage explained as Labrador-Island Link trip triggers islandwide disruption

Newfoundland power outage explained as Labrador-Island Link trip triggers islandwide disruption

A trip on the Labrador-Island Link triggered widespread power outages across Newfoundland on Friday, with service expected to return within about 30 minutes, NL Hydro said. Newfoundland Power reported outages from St. John’s to Port aux Basques and is investigating. The event involved automatic under-frequency load shedding to protect the grid. Hydro has not said what caused the trip.
February 13, 2026
Toast (TOST) stock jumps after earnings and a $500 million buyback boost — analysts split

Toast (TOST) stock jumps after earnings and a $500 million buyback boost — analysts split

Toast shares rose 4.6% to $27.33 in after-hours trading Friday after the company reported fourth-quarter profit of $101 million and revenue up 22.6% to $1.63 billion. The board approved a $500 million increase to its share buyback program. Toast forecast 2026 adjusted EBITDA of $775 million to $795 million. Needham cut its price target to $35; Bernstein reiterated $39.
February 13, 2026
1 69 70 71 72 73 157